Liberum's AstraZeneca research highlighted in Telegraph's 2014 outlook

28 December 2013 | Mentions of Liberum
AstraZeneca in Questor column

Equities research on AstraZeneca published by Liberum pharmaceuticals analyst Naresh Chouhan (below) is singled out by the editor of the Telegraph's Questor column in the newspaper's outlook for 2014 published on December 28, 2013. 

Ten of its journalists each picked an idea that would benefit from the improving business climate. Naresh's work, originally published on November 15, 2013, was the sole piece of research identified in the article by Questor Editor John Ficenic.

Other companies named in the piece that are also covered by Liberum are: Imagination Technologies. Research was published December 12, 2013 by technology analyst Eoin LambeDrax. Utilities analyst Peter Atherton published on the company November 18, 2013; Barrat Developments. Housebuilders analyst Charlie Campbell issued sector research that included the company on October 29, 2013; FirstGroup. Transport analyst Gerald Khoo initiated coverage of the UK transportation sector on December 9, 2013.

(This communication is for information purposes only and should not be regarded as an offer or solicitation to buy or sell any security. Please visit our Conflicts of Interest policy for further information.)

Liberum places £30m Conygar preference shares to fund real estate portfolio

19 December 2013 | Advisory Work

Liberum has acted as financial adviser and sole bookrunner to The Conygar Investment Company plc in respect of its recent £30 million placing of zero dividend preference shares. The funds raised will be used to invest in Conygar’s existing portfolio of real estate assets. Please contact Tim Graham or Richard Bootle on +44 (0) 20 3100 2222.

€18.5m raised for Swedish peer-to-peer lender Trustbuddy

09 December 2013 | Advisory Work

Liberum has acted as Lead Broker/Adviser to Trustbuddy on a placing to raise €18.5m. Trustbuddy is a web-based community that provides a user friendly Person to Person (P2P) lending service and specialises in making life simpler for lenders or borrowers. For further information contact Simon Atkinson on +44 (0) 20 3100 2222.

Liberum places 17.3% of leading primary healthcare property group Assura

05 December 2013 | Advisory Work

Liberum has acted as Sole Bookrunner for Assura Group for placing 17.3% of the Company, removing a significant public overhang and introducing a number of new institutional holders to the share register. For further information please contact Peter Tracey or Jamie Richards on +44 (0) 20 3100 2222.

Infinis Energy IPO raises £234m, Liberum co-lead manager

15 November 2013 | Advisory Work

Liberum has acted as Co-Lead Manager on the IPO of Infinis Energy Plc which raised £234 million for private equity owner Terra Firma. Infinis Energy is the UKs largest independent renewable energy generator with a total installed capacity of 621MW across three operating divisions including landfill gas, onshore wind and hydro power and an onshore wind development pipeline if approximately 600MW. For further information please call Tim Graham or Christopher Britton on +44 (0) 20 3100 2000.

Xchanging names Liberum corporate broker

13 November 2013 | Corporate Brokerships

Liberum has been appointed as corporate broker to Xchanging plc. Xchanging is a business process, technology and procurement services provider. It has been listed on the LSE since 2007 and has a market cap of c.£320m. Xchanging has over 8,000 employees in 10 countries that provide complex and critical outsourcing services to corporates across numerous sectors, with particular strengths in Insurance and Financials. For further information please call Peter Tracey, Neil Patel, Robert Morton or Jamie Richards on +44 (0) 20 3100 2222.